Neu Sale
STJ5063075

SARS CoV-2 Spike Glycoprotein South Africa variant Positive Control for STJ506303 peptide (South Africa variant) (STJ506307); 5applications

Art.-Nr.: STJ506307-5

SARS CoV-2 Spike Glycoprotein South Africa variant Positive Control for STJ506303 peptide (South Africa variant) (STJ506307); 5applications
ab 1 555,00 € + 19,00% MwSt.